With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...
LNTH READ THE FULL LNTH RESEARCH REPORT As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), ...
Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...
About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...
ART-101 is a novel small molecule for prostate cancer imaging and treatment, showing improved tumor uptake and reduced normal tissue uptake. The phase 1 trial will assess safety, biodistribution, and ...
Background: ATTR-CA is associated with heart failure (HF) and premature death. It is diagnosed non-invasively with radionuclide imaging, most commonly using 99mTc-pyrophosphate (PYP). Recent advances ...
About 40% of cancers among Americans can be attributed to potentially modifiable factors such as smoking, drinking, obesity, and physical inactivity. If a widely reported study from earlier this year ...
Prior CT scans linked with increase in current pregnancy risks Pregnancy risks rise with number of prior CT scans, scans near ovaries Young women should be offered alternatives to CT when possible ...
With Lutetium-177 [177Lu]Lu-PSMA-617 radiopharmaceutical therapy being FDA-approved for metastatic castration-resistant prostate cancer (mCRPC) with an improvement in overall survival (OS), 1,2 there ...